John Maibauer

Director of Regulatory Affairs at Fresenius Kabi

Based in McHenry, United States

View on LinkedIn

7-day free trial · no credit card

Seniority

Director

Department

General Business & Management

Location

McHenry

Industry

Pharmaceutical Manufacturing

Company size

24K

Contact information

Reveal John's email and phone

Direct contact data is gated. Sign up and reveal. You only pay for verified records.

Email

1 credit

j•••••••@fresenius-kabi.com

Phone

5 credits

+1 ••• •••• ••••

You only pay for valid records. Bounced emails and disconnected numbers cost nothing.

Background

About John Maibauer

An experienced leader in regulatory affairs with strong technical skills, work ethic, and regulatory knowledge. Given my computer sciences degree and experience at a copy center i was hired into regulatory affairs to work on regulatory operations. I was able to quickly learn regulatory concepts and transition from RA operations to RA strategy. I am able to leverage my technical background to better understand the products i work on and apply the relevant regulatory concepts. ACHIEVEMENTS As a Manager/Leader- Successfully developed team to manage SaaMD (recruited, hired, trained, and mentored staff)- Led, Coached, and Managed direct reports through multiple 510(k)s, IDE’s, CE Mark packages, & a Drug Master File - Led, Coached, and Managed direct report through development of next generation Dose Error Reduction System - RA lead on cybersecurity initiatives for division, helped implement policies and procedures Individual- Authored and received clearance for nine 510(k)s as submission owner - Authored and received 510(k) clearance for the company’s first SaaMD (Software as a Medical Device)- Authored and received approval for a Prior Approval NDA Supplement - Developed, led, and executed regulatory strategy for three brand new products, from concept to launch - Created and maintained ERC and STED file for multiple brand-new product families - Submitted applications and received 510(k) clearance and CE mark approval for 3 new indications on existing products (Plasma Procedure on Alyx, ECP for Amicus, PF24 for Amicus & Alyx)- Developed and implemented systems and processes for registration, project, and change management tracking as well as SPL authoring - Led RA strategy for Combination Product including authoring an RFD and receiving IDE approval for a Clinical Trial - Led many teleconferences with FDA, a face to face meeting with FDA, and a face to face meeting with an EU notified body

Decision-makers

Other people at Fresenius Kabi

Browse the Fresenius Kabi team →

Build a list of verified contacts at Fresenius Kabi

Free for 7 days · 50 credits · no card · only pay for verified records.

Start free

Reach more buyers like John

250M+ professionals with verified email and phone. You only pay for records that actually verify.

7-day trial · no credit card · cancel anytime

John Maibauer Email & Phone Number @ Fresenius Kabi | Kipplo Discover